OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
24
Results
Show all
Save search
Copy query
Show results for
Unknown
(24)
Publication Date
Release Date
2017
(5)
2016
(4)
2022
(2)
2021
(2)
2015
(2)
2014
(2)
2013
(2)
2011
(2)
2023
(1)
2018
(1)
2008
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Not available
S-EPMC5538020
|
biostudies-literature
Cite
The current use and attitudes towards tumor genome sequencing in breast cancer.
Not available
S-EPMC4773754
|
biostudies-literature
Cite
Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.
Not available
S-EPMC5006510
|
biostudies-literature
Cite
Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Not available
S-EPMC6279283
|
biostudies-literature
Cite
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer.
Not available
S-EPMC9424318
|
biostudies-literature
Cite
Transcription profiling of human invasive breast carcinomas and data analysis from published studies to understand the molecular basis of histologic grade to improve prognosis
Not available
ORGANISM(S):
Homo sapiens
S-ECPF-GEOD-2990
|
biostudies-other
Cite
Transcription profiling by array of human breast cancers after treatment with tamoxifen
Not available
ORGANISM(S):
Homo sapiens
S-ECPF-GEOD-6532
|
biostudies-other
Cite
Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer.
Not available
S-EPMC11195534
|
biostudies-literature
Cite
Transcription profiling of human primary breast tumors to validate a 76-gene prognostic signature reveals strong time dependence of the 76-gene prognostic signature
Not available
ORGANISM(S):
Homo sapiens
S-ECPF-GEOD-7390
|
biostudies-other
Cite
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.
Not available
S-EPMC5465633
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets